Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOEX.L Regulatory News (OEX)

  • There is currently no data for OEX

Appendix 3B

17 Sep 2012 07:47

RNS Number : 3838M
Oilex Limited
17 September 2012
 



 

 

 

 

 

 

17 September 2012

 

 

 

Appendix 3B

 

We enclose an Appendix 3B detailing the expiration of the following unlisted Options:

 

 

2,000,000 options exercisable @ $0.30 expiry date 15 September 2012

 

 

 

For and on behalf of Oilex Ltd

 

 

 

 

 

Max Cozijn

Chairman

 

 

cc: Directors - BMc/RB/SB/RM

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

 

 

Appendix 3B

 

New issue announcement,application for quotation of additional securitiesand agreement

 

 

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

 

Introduced 1/7/96. Origin: Appendix 5. Amended 1/7/98, 1/9/99, 1/7/2000, 30/9/2001, 11/3/2002, 1/1/2003, 24/10/2005, 01/08/2012.

 

 

Name of entity

 OILEX LTD

 

ABN

50 078 652 632

 

We (the entity) give ASX the following information.

 

 

Part 1 ‑ All issues

You must complete the relevant sections (attach sheets if there is not enough space).

 

1.

+Class of +securities issued or to be issued

 

2.

Number of +securities issued or to be issued (if known) or maximum number which may be issued

 

3.

Principal terms of the +securities (eg, if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion)

 

 

 

 

4.

Do the +securities rank equally in all respects from the date of allotment with an existing +class of quoted +securities?

 

If the additional securities do not rank equally, please state:

·; the date from which they do

·; the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

·; the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

 

 

 

 

 

 

 

5.

Issue price or consideration

 

 

 

 

 

6.

Purpose of the issue

(If issued as consideration for the acquisition of assets, clearly identify those assets)

 

 

6a

Is the entity an +eligible entity that has obtained security holder approval under rule 7.1A?

 

If Yes, complete sections 6b - 6h in relation to the +securities the subject of this Appendix 3B, and comply with section 6i

 

 

6b

The date the security holder resolution under rule 7.1A was passed

 

 

6c

Number of +securities issued without security holder approval under rule 7.1

 

 

 

6d

Number of +securities issued with security holder approval under rule 7.1A

 

 

6e

Number of +securities issued with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting)

 

 

 

6f

Number of securities issued under an exception in rule 7.2

 

 

6g

If securities issued under rule 7.1A, was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the issue date and both values. Include the source of the VWAP calculation.

 

 

6h

If securities were issued under rule 7.1A for non-cash consideration, state date on which valuation of consideration was released to ASX Market Announcements

 

 

6i

Calculate the entity's remaining issue capacity under rule 7.1 and rule 7.1A - complete Annexure 1 and release to ASX Market Announcements

 

7.

Dates of entering +securities into uncertificated holdings or despatch of certificates

 

 

 

 

Number

+Class

8.

Number and +class of all +securities quoted on ASX (including the securities in clause 2 if applicable)

 

 

 

 

354,654,839

 

151,994,971

 

Ordinary Shares

 

Options

 

  

 

 

Number

+Class

9.

Number and +class of all +securities not quoted on ASX (including the securities in clause 2 if applicable)

 

 

 

16,687,500

75,000

4,150,000

8,737,500

75,000

 

 

 

$0.30 Options due 10/11/2012

$0.50 Options due 01/08/2013

$0.30 Options due 01/07/2014

$0.37 Options due 10/11/2014

$0.63 Options due 01/08/2015

 

2008 Performance Rights

 

22,000

Tranche 3 expire 1/07/2013

10.

Dividend policy (in the case of a trust, distribution policy) on the increased capital (interests)

 

 

 

 

 Part 2 ‑ Bonus issue or pro rata issue [Item 11 to 33 - Not Applicable]

 

 

 

Part 3 ‑ Quotation of securities

You need only complete this section if you are applying for quotation of securities

 

34

Type of securities

(tick one)

(a)

Securities described in Part 1

(b)

All other securities

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

 

 

 

 

 

Entities that have ticked box 34(a) [Items 35 to 42 - Not Applicable]

Additional securities forming a new class of securities

 

Quotation agreement

 

1. +Quotation of our additional +securities is in ASX's absolute discretion. ASX may quote the +securities on any conditions it decides.

 

2. We warrant the following to ASX.

 

·; The issue of the +securities to be quoted complies with the law and is not for an illegal purpose.

·; There is no reason why those +securities should not be granted +quotation.

·; An offer of the +securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

 

·; Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any +securities to be quoted and that no-one has any right to return any +securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the +securities be quoted.

·; We warrant that if confirmation is required under section 1017F of the Corporations Act in relation to the +securities to be quoted, it has been provided at the time that we request that the +securities be quoted.

·; If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the +securities be quoted.

 

3. We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

 

4. We give ASX the information and documents required by this form. If any information or document not available now, will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

 

 

Sign here: .............................................. Date: 17 September 2012

 

(Chairman)

 

 

Print name: Max Cozijn

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLIFVRADIDLIF
Date   Source Headline
15th Aug 20187:00 amRNSNotice of General Meeting
13th Aug 20187:30 amRNSRestoration - Oilex Limited
13th Aug 20187:00 amRNSGSPC Event of Default Update & Trading Restoration
10th Aug 201812:35 pmRNSSuspension - Oilex Ltd
10th Aug 20187:00 amRNSTrading Halt
6th Aug 20187:05 amRNSExpiry of Unlisted Options
31st Jul 20187:00 amRNSJune 2018 Quarterly Report
30th Jul 20187:00 amRNSEvent of Default Notice Update
30th Jul 20187:00 amRNSTranche 2 Update
26th Jul 20187:00 amRNSLoan Funding & Cash Call Receipt
29th May 20187:00 amRNSIssue of Event of Default Notice - Cambay PSC
17th May 20187:00 amRNSNotice Change of Interests of Substantial Holder
15th May 20187:00 amRNSAppendix 3Y P Haywood
15th May 20187:00 amRNSAppendix 3Y B Lingo
15th May 20187:00 amRNSAppendix 3B Issue of Shares and Section 708 Notice
30th Apr 201810:19 amRNSMarch 2018 Quarterly Report
30th Apr 201810:11 amRNSCapital Raising and T2 Variation
4th Apr 20187:00 amRNSMoPNG Approves Application for PSC Extensions
29th Mar 20187:00 amRNSAmendment to T2 Capital Raising Conditions
15th Mar 20187:00 amRNSManaging Director Contract Extension
14th Mar 20187:00 amRNSResults of 14 March 2018 General Meeting
1st Mar 20187:00 amRNSAppendix 3Y P Haywood
1st Mar 20187:00 amRNSAppendix 3Y B Lingo
1st Mar 20187:00 amRNSAppendix 3B Issue of Shares and Section 708 Notice
26th Feb 20187:00 amRNSInvestor Presentation February 2018
22nd Feb 20187:47 amRNSInterim Report 31 December 2017
12th Feb 20187:00 amRNSNotice of General Meeting
1st Feb 20187:00 amRNSNotice of Initial Substantial Holder
29th Jan 20187:00 amRNSAppendix 3B Issue of Shares and Section 708 Notice
29th Jan 20187:00 amRNSQuarterly Report 31 December 2017
22nd Dec 20177:00 amRNSExpiry of Unlisted Options
12th Dec 20178:29 amRNSAppendix 3B Issue of Shares and Section 708 Notice
12th Dec 20177:00 amRNSPlacement to New Cornerstone Shareholder
29th Nov 20177:00 amRNSChairman's Address to Shareholders
29th Nov 20177:00 amRNSAppendix 3Z M Cozijn
29th Nov 20177:00 amRNSResults of Annual General Meeting 29 November 2017
23rd Nov 20177:00 amRNSExpiry of Unlisted Options
13th Nov 201712:43 pmRNSInvestor Presentation November 2017
13th Nov 20177:00 amRNSExpiry of Unlisted Options
30th Oct 20177:00 amRNS2017 AGM Notice of Meeting
30th Oct 20177:00 amRNS2017 Annual Report to Shareholders
30th Oct 20177:00 amRNSBoard Changes
26th Oct 20179:50 amRNSQuarterly Report 30 September 2017
13th Sep 20177:00 amRNSCorporate Governance Statement
13th Sep 20177:00 amRNSGood Oil Investor Presentation September 2017
12th Sep 20179:40 amRNSFinancial Report for Year Ended 30 June 2017
12th Sep 20179:31 amRNSAppendix 4G
12th Sep 20179:29 amRNSUpdated Constitution
4th Sep 20178:07 amRNSAppendix 3B Issue of Shares and Section 708 Notice
29th Aug 20177:00 amRNSOilex Investor Presentation August 2017

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.